期刊
RHEUMATOLOGY INTERNATIONAL
卷 30, 期 11, 页码 1503-1505出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00296-009-1098-x
关键词
Lupus myocarditis; Treatment; Immunoglobulin
类别
Intravenous immunoglobulin (IVIg) is emerging as the mainstay in the treatment of many autoimmune diseases, including systemic lupus erythematosus. IVIg has been found to be beneficial in myocarditis due to dermatomyositis/polymyositis, Kawasaki disease, and viral myocarditis in children. We report an 18-year-old man of active lupus with worsening cardiac systolic function who did not respond to pulse methylprednisolone and cyclophosphamide, but subsequently showed an improvement in his cardiac function after IVIg administration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据